Bioline Rx reported $3.48M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Arca Biopharma USD 36.43M 2M Mar/2026
Bio Path USD 297K 191K Mar/2026
Bioline Rx USD 3.48M 99K Mar/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025